SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab gains on reporting stellar Q1 numbers

25 Jul 2014 Evaluate

Strides Arcolab is currently trading at Rs 675.95, up by 7.00 points or 1.05% from its previous closing of Rs. 668.95 on the BSE.

The scrip opened at Rs 672.00 and has touched a high and low of Rs 689.00 and Rs 656.50 respectively. So far 155469 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 1050.00 on 05-Dec-2013 and a 52 week low of Rs 343.80 on 26-Feb-2014.

Last one week high and low of the scrip stood at Rs 696.00 and Rs 651.40 respectively. The current market cap of the company is Rs 4014.72 crore.

The promoters holding in the company stood at 27.67% while Institutions and Non-Institutions held 50.73% and 21.59% respectively.

Strides Arcolab has reported results for first quarter ended June 30, 2014.

The company’s net profit jumped over 12 fold at Rs 26.80 crore as compared to Rs 2.16 crore for the quarter ended June 30, 2013. The company’s total income has surged by 22.95% to Rs 226.28 crore for the quarter under review from Rs 184.04 crore for the corresponding quarter of the previous year.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×